Royal Bank of Canada’s Xenetic Biosciences XBIO Stock Holding History

Royal Bank of Canada’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,300	Closed	-$17K	–	7669
2023 Q2	$17K	Buy	+5,300	New	+$19.7K	﹤0.01%	6296
2023 Q1	–	Sell	-30	Closed	–	–	7550
2022 Q4	$0	Buy	+30	New	+$132	﹤0.01%	7788
2021 Q2	–	Sell	-2,699	Closed	-$59K	–	7718
2021 Q1	$59K	Hold	2,699	–	–	﹤0.01%	5788
2020 Q4	$55K	Hold	2,699	–	–	﹤0.01%	5624
2020 Q3	$24K	Hold	2,699	–	–	﹤0.01%	5629
2020 Q2	$28K	Hold	2,699	–	–	﹤0.01%	5460
2020 Q1	$20K	Hold	2,699	–	–	﹤0.01%	5556
2019 Q4	$39K	Hold	2,699	–	–	﹤0.01%	5560
2019 Q3	$32K	Hold	2,699	–	–	﹤0.01%	5303
2019 Q2	$304K	Hold	2,699	–	–	﹤0.01%	4200
2019 Q1	$628K	Hold	2,699	–	–	﹤0.01%	3581
2018 Q4	$531K	Hold	2,699	–	–	﹤0.01%	3668
2018 Q3	$917K	Hold	2,699	–	–	﹤0.01%	3426
2018 Q2	$1.32M	Hold	2,699	–	–	﹤0.01%	3021
2018 Q1	$696K	Hold	2,699	–	–	﹤0.01%	3450
2017 Q4	$621K	Hold	2,699	–	–	﹤0.01%	3631
2017 Q3	$654K	Hold	2,699	–	–	﹤0.01%	3587
2017 Q2	$894K	Hold	2,699	–	–	﹤0.01%	3191
2017 Q1	$1.47M	Hold	2,699	–	–	﹤0.01%	2776
2016 Q4	$1.39M	Buy	+2,699	New	+$1.16M	﹤0.01%	2865

Other funds holding XBIO

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's XBIO Position: Q3 2023 in Review

Royal Bank of Canada sold out of Xenetic Biosciences (XBIO) in Q3 2023, closing a stake of 5,300 shares — an estimated $17K sold.

Royal Bank of Canada first reported a position in XBIO in Q4 2016 and held it in 20 quarters. The position peaked at $1.47M in Q1 2017. 7 funds tracked by Wall St. Rank hold XBIO as of Q3 2023.

Royal Bank of Canada reported no remaining Xenetic Biosciences position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 5,300 Xenetic Biosciences shares in Q3 2023, an estimated $17K.
Royal Bank of Canada first reported a position in Xenetic Biosciences in Q4 2016 and held it in 20 quarters.
Royal Bank of Canada's Xenetic Biosciences position peaked at $1.47M in Q1 2017.
7 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.